Fidelity Investments’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.2M | Buy |
446,305
+3,313
| +0.7% | +$31.2K | ﹤0.01% | 2226 |
|
|
2025
Q1 | $2.4M | Buy |
442,992
+400,718
| +948% | +$2.17M | ﹤0.01% | 2387 |
|
|
2024
Q4 | $315K | Buy |
42,274
+40,477
| +2,252% | +$302K | ﹤0.01% | 3086 |
|
|
2024
Q3 | $14.4K | Sell |
1,797
-73
| -4% | -$583 | ﹤0.01% | 4306 |
|
|
2024
Q2 | $16.3K | Sell |
1,870
-30,539
| -94% | -$266K | ﹤0.01% | 4141 |
|
|
2024
Q1 | $670K | Sell |
32,409
-76
| -0.2% | -$1.57K | ﹤0.01% | 2628 |
|
|
2023
Q4 | $751K | Buy |
32,485
+30,088
| +1,255% | +$695K | ﹤0.01% | 2548 |
|
|
2023
Q3 | $19.2K | Buy |
2,397
+719
| +43% | +$5.75K | ﹤0.01% | 3829 |
|
|
2023
Q2 | $14.6K | Buy |
1,678
+692
| +70% | +$6.02K | ﹤0.01% | 3999 |
|
|
2023
Q1 | $2.9K | Sell |
986
-1,576
| -62% | -$4.63K | ﹤0.01% | 4532 |
|
|
2022
Q4 | $8.97K | Buy |
2,562
+2,493
| +3,613% | +$8.73K | ﹤0.01% | 4049 |
|
|
2022
Q3 | $1K | Buy |
69
+30
| +77% | +$435 | ﹤0.01% | 4658 |
|
|
2022
Q2 | $0 | Sell |
39
-182,321
| -100% | – | ﹤0.01% | 5076 |
|
|
2022
Q1 | $2.22M | Sell |
182,360
-217,640
| -54% | -$2.64M | ﹤0.01% | 2579 |
|
|
2021
Q4 | $4.9M | Buy |
400,000
+399,996
| +9,999,900% | +$4.9M | ﹤0.01% | 2369 |
|
|
2021
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 4550 |
|
|
2019
Q1 | – | Sell |
-47
| Closed | -$1K | – | 3765 |
|
|
2018
Q4 | $1K | Buy |
+47
| New | +$1K | ﹤0.01% | 3391 |
|
|
2014
Q3 | – | Sell |
-19,630
| Closed | -$852K | – | 2790 |
|
|
2014
Q2 | $852K | Sell |
19,630
-7,650
| -28% | -$332K | ﹤0.01% | 2528 |
|
|
2014
Q1 | $1.12M | Buy |
27,280
+15,110
| +124% | +$619K | ﹤0.01% | 2461 |
|
|
2013
Q4 | $483K | Buy |
+12,170
| New | +$483K | ﹤0.01% | 2517 |
|